APA (7th ed.) Citation

Vasse, M., Zuber, B., Goubeau, L., Ballester, M., Roumier, M., Delcominette, F., . . . Pascreau, T. (2021). A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity. Clinical chemistry and laboratory medicine, 59(7), 1315-1322. https://doi.org/10.1515/cclm-2020-1801

Chicago Style (17th ed.) Citation

Vasse, Marc, et al. "A Low Level of CD16pos Monocytes in SARS-CoV-2 Infected Patients Is a Marker of Severity." Clinical Chemistry and Laboratory Medicine 59, no. 7 (2021): 1315-1322. https://doi.org/10.1515/cclm-2020-1801.

MLA (9th ed.) Citation

Vasse, Marc, et al. "A Low Level of CD16pos Monocytes in SARS-CoV-2 Infected Patients Is a Marker of Severity." Clinical Chemistry and Laboratory Medicine, vol. 59, no. 7, 2021, pp. 1315-1322, https://doi.org/10.1515/cclm-2020-1801.